Change In Working Capital - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ryvu Therapeutics SA
Change in Working Capital Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Change in Working Capital
-zł12.2m
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Change in Working Capital
zł3.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Medicofarma Biotech SA
WSE:MDB
Change in Working Capital
zł534.4k
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Change in Working Capital
zł15.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Change in Working Capital?
Change in Working Capital
-12.2m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Change in Working Capital amounts to -12.2m PLN.

What is Ryvu Therapeutics SA's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
23%

Back to Top